ClassID:

96429

C07H19/12 - CPC Classification

Classification description:

Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom Triazine radicals

Recent Application in this class:
#1
20250257056
2025-08-14

ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES

#2
20250145654
2025-05-08

COMPOUNDS AND METHODS FOR TREATING DISEASE

#3
20240300992
2024-09-12

Synthesis of Protected 3'-amino Nucleoside Monomers

#4
20240124427
2024-04-18

Hydroxyheterocycloalkane-carbamoyl derivatives

#5
20240116972
2024-04-11

6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS

#6
20240034748
2024-02-01

Synthesis of Protected 3'-amino Nucleoside Monomers

#7
20230416294
2023-12-28

DECITABINE ANALOGS FOR IMMUNOLOGICAL AND ONCOLOGICAL THERAPY

#8
20230374058
2023-11-23

Compounds and methods for treating disease

#9
20230348442
2023-11-02

Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives

#10
20230295182
2023-09-21

Spiro derivatives of Alpha-D-galactopyranosides

#11
20230089101
2023-03-23

Synthesis of Protected 3'-amino Nucleoside Monomers

#12
20230062181
2023-03-02

ALKYNE CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

#13
20220324847
2022-10-13

2-hydroxycycloalkane-1-carbamoyl

#14
20220281855
2022-09-08

Alpha-D-galactopyranoside derivatives

#15
20220204545
2022-06-30

6-aza-nucleoside prodrugs as antiviral agents for treating virus infections

#16
20210363170
2021-11-25

4'-THIO-NUCLEOTIDE AND -NUCLEOSIDE PRODRUGS FOR THE TREATMENT OF CANCER

#17
20210361777
2021-11-25

PHARMACEUTICAL PRODRUGS AND METHODS OF THEIR PREPARATION AND USE

#18
20210261998
2021-08-26

COMPOSITIONS AND METHODS RELATED TO NUCLEIC ACID PREPARATION

#19
20210253622
2021-08-19

2′-substituted carba-nucleoside analogs for antiviral treatment

#20
20210179656
2021-06-17

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#21
20210147466
2021-05-20

IMPROVED PROCESSES FOR THE PREPARATION OF GUADECITABINE AND INTERMEDIATES THEREOF

#22
20200377543
2020-12-03

Synthesis of Protected 3'-Amino Nucleoside Monomers

#23
20200024297
2020-01-23

Substituted nucleosides, nucleotides and analogs thereof

#24
20190381081
2019-12-19

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#25
20190345189
2019-11-14

Method for preparing a ß-nucleoside compound

#26
20190315793
2019-10-17

Alpha-D-galactoside inhibitors of galectins

#27
20190240348
2019-08-08

Pharmaceutical prodrugs and methods of their preparation and use

#28
20190169221
2019-06-06

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#29
20190144484
2019-05-16

Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

#30
20190085013
2019-03-21

NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

#31
20190031707
2019-01-31

Synthesis of protected 3′-amino nucleoside monomers

#32
20190016749
2019-01-17

2′-substituted carba-nucleoside analogs for antiviral treatment

#33
20180179246
2018-06-28

Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety

#34
20180066295
2018-03-08

DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES

#35
20180016609
2018-01-18

A Process for the Preparation of Nucleic Acid by Means of 3'-O-Azidomethyl Nucleotide Triphosphate

#36
20180002366
2018-01-04

4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

#37
20170313736
2017-11-02

MUTAGENIC NUCLEOSIDE ANALOGS AND USES THEREOF

#38
20170305941
2017-10-26

Silylated pyrimidine prodrugs and methods of their use

#39
20170304337
2017-10-26

Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety

#40
20170037078
2017-02-09

2' -DISUBSTITUTED NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER

#41
20160362440
2016-12-15

Synthesis of protected 3′-amino nucleoside monomers

#42
20160331770
2016-11-17

Substituted nucleosides, nucleotides and analogs thereof

#43
20160296546
2016-10-13

Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof

#44
20160264614
2016-09-15

POLYNUCLEOTIDE MOLECULES AND USES THEREOF

#45
20160222050
2016-08-04

Mutagenic nucleoside analogs and uses thereof

#46
20160168182
2016-06-16

Method for the purification of decitabine

#47
20150315228
2015-11-05

Substituted nucleosides, nucleotides and analogs thereof

#48
20150284421
2015-10-08

Formulation of 5-azacytidine

#49
20150274767
2015-10-01

4′-substituted nucleoside reverse transcriptase inhibitors

#50
20150266918
2015-09-24

Bridged-cyclo-ProTides as prodrugs of therapeutic nucleosides and nucleotides

#51
20150246068
2015-09-03

Nucleotide prodrug compounds and use

#52
20150240295
2015-08-27

REACTIVE, LIPOPHILIC NUCLEOSIDE BUILDING BLOCKS FOR THE SYNTHESIS OF HYDROPHOBIC NUCLEIC ACIDS

#53
20150051167
2015-02-19

Substituted nucleosides, nucleotides and analogs thereof

#54
20150038692
2015-02-05

Synthesis of protected 3′-amino nucleoside monomers

#55
20140329768
2014-11-06

Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates

#56
20140206640
2014-07-24

2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

#57
20140155588
2014-06-05

Azacitidine process and polymorphs

#58
20140135490
2014-05-15

Synthesis of nucleosides

#59
20140128593
2014-05-08

Synthesis of 5-azacytidine

#60
20140107058
2014-04-17

Pharmaceutical compositions comprising forms of 5-azacytidine

#61
20140099283
2014-04-10

2′-chloro nucleoside analogs for HCV infection

#62
20140094598
2014-04-03

METHOD FOR THE PURIFICATION OF DECITABINE

#63
20140038916
2014-02-06

O-(substituted benzyl) phosphoramidate compounds and therapeutic use

#64
20140024612
2014-01-23

Fluorinated pyrimidine analogs and methods of use thereof

#65
20130274459
2013-10-17

Methods for isolating crystalline form I of 5-azacytidine

#66
20130243725
2013-09-19

2′-substituted carba-nucleoside analogs for antiviral treatment

#67
20130210757
2013-08-15

Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs

#68
20130165400
2013-06-27

Substituted nucleosides, nucleotides and analogs thereof

#69
20130085133
2013-04-04

ANTI-VIRAL TREATMENT AND ASSAY TO SCREENFOR ANTI-VIRAL AGENT

#70
20130078217
2013-03-28

2′-chloroacetylenyl substituted nucleoside derivatives

#71
20130059810
2013-03-07

Pharmaceutical compositions comprising forms of 5-azacytidine

#72
20130059809
2013-03-07

Pharmaceutical compositions comprising forms of 5-azacytidine

#73
20130008238
2013-01-10

PROCESS FOR PREPARING AZACYTIDINE INTERMEDIATE

#74
20120264706
2012-10-18

Purine derivatives as adenosine A1 receptor agonists and methods of use thereof

#75
20120245342
2012-09-27

Methods for isolating crystalline form I of 5-azacytidine

#76
20120149657
2012-06-14

2'-FLUORO ARABINO NUCLEOSIDES AND USE THEREOF

#77
20120108535
2012-05-03

2-fluorinated riboses and arabinoses and methods of use and synthesis

#78
20120046457
2012-02-23

PREPARATION OF DECITABINE

#79
20120029181
2012-02-02

SYNTHESIS OF 5-AZACYTIDINE

#80
20110288042
2011-11-24

STABLE HIGHLY PURE AZACITIDINE AND PREPARATION METHODS THEREFOR

#81
20110245485
2011-10-06

Process for the synthesis of azacitidine and decitabine

#82
20110201800
2011-08-18

Azacitidine process and polymorphs

#83
20110092694
2011-04-21

Synthesis of 5-azacytidine

#84
20100298253
2010-11-25

Pharmaceutical compositions comprising 5-azacytidine monohydrate

#85
20100292180
2010-11-18

Pharmaceutical compositions comprising crystal forms of 5-azacytidine

#86
20100267657
2010-10-21

Antimetabolite agent combinations in the treatment of cancer

#87
20100249394
2010-09-30

PROCESSES FOR PRODUCING DECITABINE

#88
20100234585
2010-09-16

Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives

#89
20100222565
2010-09-02

METHOD OF PRODUCING 2'-DEOXY-5-AZACYTIDINE (DECITABINE)

#90
20100210833
2010-08-19

METHOD OF PRODUCING NUCLEOSIDES

#91
20100087637
2010-04-08

Synthesis of decitabine

#92
20100062992
2010-03-11

Salts of 5-Azacytidine

#93
20100048917
2010-02-25

PREPARATION OF ALKYL-SUBSTITUTED 2-DEOXY-2-FLUORO-D-RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVES

#94
20100036112
2010-02-11

Process for making 5-azacytosine nucleosides and their derivatives

#95
20100035354
2010-02-11

PROCESS FOR PREPARING AZACYTIDINE INTERMEDIATE

#96
20090318676
2009-12-24

Oligonucleotides comprising a non-phosphate backbone linkage

#97
20090281299
2009-11-12

Oligonucleotides comprising a non-phosphate backbone linkage

#98
20090209482
2009-08-20

Azacytidine analogues and uses thereof

#99
20090209477
2009-08-20

Azacytidine analogues and uses thereof

#100
20090105468
2009-04-23

Synthesis of protected 3′-amino nucleoside monomers

#101
20090075920
2009-03-19

DEUTERIUM-ENRICHED DECITABINE

#102
20090062314
2009-03-05

Purine derivatives as adenosine Areceptor agonists and methods of use thereof

#103
20090005551
2009-01-01

Synthesis of 5-azacytidine

#104
20080287378
2008-11-20

Solid state forms of 5-azacytidine and processes for preparation thereof

#105
20080152702
2008-06-26

Releasable linkage and compositions containing same

#106
20080033172
2008-02-07

Mutagenic Heterocycles

#107
20080009496
2008-01-10

MUTAGENIC HETEROCYCLES

#108
20070275912
2007-11-29

Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase

#109
20070207973
2007-09-06

1,3,5-Triazines for Treatment of Viral Diseases

#110
20070197463
2007-08-23

Antiviral nucleosides

#111
20070142310
2007-06-21

1,3,5-triazines for treatment of viral diseases

#112
20070135375
2007-06-14

Sulfamoyl sulfonate prodrugs

#113
20070100138
2007-05-03

Monomer compositions for the synthesis of polynucleotides, methods of synthesis, and methods of deprotection

#114
20070100136
2007-05-03

Monomer compositions for the synthesis of RNA, methods of synthesis, and methods of deprotection

#115
20070066815
2007-03-22

Selective O-acylation of nucleosides

#116
20070015914
2007-01-18

Stereoselective synthesis of β-nucleosides

#117
20070004669
2007-01-04

Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase

#118
20060287260
2006-12-21

Oligonucleotides comprising a non-phosphate backbone linkage

#119
20060276638
2006-12-07

Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonate and use thereof for making a beta nucleoside

#120
20060264390
2006-11-23

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

#121
20060258614
2006-11-16

Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation

#122
20060247432
2006-11-02

Synthesis of 5-Azacytidine

#123
20060247189
2006-11-02

Forms of 5-azacytidine

#124
20060241071
2006-10-26

Functional synthetic molecules and macromolecules for gene delivery

#125
20060205686
2006-09-14

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

#126
20060199783
2006-09-07

Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives

#127
20060074046
2006-04-06

Oral administration of decitabine salt

#128
20060069060
2006-03-30

Salts of decitabine

#129
20060063735
2006-03-23

Salts of 5-azacytidine

#130
20060040890
2006-02-23

Anti-viral nucleosides

#131
20060014949
2006-01-19

Compositions and formulations of decitabine polymorphs and methods of use thereof

#132
20060009636
2006-01-12

Synthesis of protected 3′-amino nucleoside monomers

#133
20060003963
2006-01-05

Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material

#134
20050282768
2005-12-22

Purine Derivatives as adenosine Areceptor agonists and methods of use thereof

#135
20050272676
2005-12-08

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

#136
20050272675
2005-12-08

Methods for isolating crystalline form I of 5-azacytidine

#137
20050271715
2005-12-08

Conjugate having a cleavable linkage for use in a liposome

#138
20050191646
2005-09-01

Nucleic acid analysis techniques

#139
20050164268
2005-07-28

Nucleic acid labeling compounds

#140
20050158772
2005-07-21

Nucleic acid analysis techniques

#141
20050137150
2005-06-23

Forms of 5-Azacytidine

#142
20050123597
2005-06-09

Releasable linkage and compositions containing same